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Abstract 
The direct detection of ancient Mycobacterium tuberculosis molecular biomarkers has 
profoundly changed our understanding of the disease in ancient and historical times. Initially 
diagnosis was based on visual changes to skeletal human remains, supplemented by 
radiological examination. The introduction of biomolecular methods has enabled the specific 
identification of tuberculosis in human tissues and has expanded our knowledge of the 
palaeopathological changes associated with the disease.  We now realise that the incidence 
of past tuberculosis was greater than previously estimated as M. tuberculosis biomarkers 
can be found in calcified and non-calcified tissues with non-specific or no visible pathological 
changes. Modern concepts on the origin and evolution of tuberculosis are informed by the 
detection of lineages of known location and date. 
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Early morphological studies 
‘You have to know the past to understand the present’    Dr Carl Sagan (1934–1996)  
 
Tuberculosis is a disease that was recognised in ancient times, primarily by the 
characteristic changes to the spine (kyphosis or gibbus) that result in Pott’s Disease. The 
eminent Greek physician Hippocrates (460–370 BC) gives a clear description of kyphosis, 
stating that it can be the result of disease, can occur above or below the diaphragm, is 
associated with hard tubercles in the lungs, and abscesses in the lumbar region [1]. He also 
noted that patients had a poor prognosis if the spinal curvature was above the diaphragm 
and if the patient was a child or young adult. Many other ancient and historical texts contain 
recognisable descriptions of tuberculosis, where the disease is identified as phthisis, 
scrofula, King’s Evil, lupus vulgaris, consumption, etc  [2]. As palaeopathology emerged from 
physical anthropology and forensic science as a distinct discipline, diagnostic criteria based 
on skeletal changes were agreed [3,4].  
 
As part of an on-going process, detailed morphological studies were performed on more 
recent historical skeletal collections with contemporaneous records of the individual cases, 
including age, sex, occupation, symptoms and cause of death [5–7]. This led to the 
realisation that some bony changes, such as periostitis (surface changes due to new bone 
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formation) on ribs, were significantly associated with individuals who had been diagnosed as 
having clinical tuberculosis. Other conditions linked to recognised tuberculosis changes 
include hypertrophic osteoarthropathy (HOA) [8,9] and serpens endocrania symmetrica 
(SES) – a morphological sign of respiratory distress and increased vascularisation around 
the brain [8]. 
 
The use of palaeohistology [10] also aids the recognition of more subtle changes associated 
with tuberculosis in calcified and non–calcified tissues. Mummified remains can demonstrate 
signs of tuberculosis such as granulomas in lung and other organs. Indeed, Allison et al [11] 
used histological methods to re-hydrate such tissue from a pre-Columbian Andean mummy 
(200–800 AD) and demonstrated bacteria within granulomas that were acid-fast by the Ziehl-
Neelson stain, with the typical microscopic appearance of mycobacteria. Radiological 
imaging gives additional data, and the use of computerised tomography (CT) facilitates the 
three-dimensional examination of morphological features. Micro-CT is becoming used more 
frequently, although there are concerns at the increased radiation load that may impact on 
the recovery of biomolecular markers such as ancient DNA (vide infra).    
 
Early studies, based on visual appearance, radiology, and a limited number of microscopic 
and histological investigations, led to the conclusion that tuberculosis definitely occurred in 
ancient populations but that it was comparatively rare. The earliest cases recognised were 
from Neolithic times [12,13], so the hypothesis that tuberculosis was associated with animal 
domestication and that human TB originated from Mycobacterium bovis [3] became widely 
accepted. The significance of the finding of acid-fast bacilli within granulomas in Pre-
Columbian mummified tissue [11] was not generally appreciated, and several subsequent 
publications included the suggestion that Columbus and subsequent European contacts 
introduced tuberculosis to the Americas. 
 
Early biomolecular studies 
The use of cloning to detect DNA from the extinct quagga in 1984 [14] opened up the 
prospect of direct genetic studies of archaeological material. However, this only became 
practicable after the development of PCR [15], which enables rapid amplification of specific 
genetic loci defined by oligonucleotide primers. There was an explosion of studies based on 
extinct animals, plants and other remains, several of which are now suspect due to the lack 
of appropriate measures to prevent contamination with modern DNA. The early development 
of this field in archaeology and palaeontology had a strong influence on the initial criteria that 
emerged, on the necessary precautions required for the production of verifiable data based 
on ancient DNA (aDNA) [16,17]. These have since been modified [18] to take account of our 
increased understanding of the sources of contamination [19] and the stability of MTBC 
aDNA [20] compared with other biomolecules [21,22]. 
 
Tuberculosis was the first infectious disease to be successfully detected by PCR in bones 
[23] and mummified tissue [24], due to a fortuitous combination of circumstances. There 
were agreed morphological diagnostic criteria, appropriate DNA extraction procedures had 
been developed and clinical microbiologists had designed specific PCR primers. The driving 
force for molecular diagnostics of tuberculosis was the extremely slow growth rate of the 
causative organism, Mycobacterium tuberculosis and the other closely related members of 
the M. tuberculosis complex (MTBC). Clinical treatment is the same for all members of the 
MTBC so no attempt was made at the time to distinguish between its members. The first 
primers used were based on an MTBC-specific locus in the insertion sequence IS6110 and 
because it is usually present in multiple copies within the bacterial cell, it was the preferred 
locus for detection of tubercle bacilli. These early studies confirmed tuberculosis in 
Byzantine Turkey, pre-European contact Borneo, and a pre-Columbian Andean mummy 
(1000 BP). They were quickly followed by reports of MTBC aDNA in ancient Egypt, China, 
America and Europe, summarised in a series of reviews [18, 25–29].  
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It soon became apparent that MTBC aDNA could be detected in material with non- specific 
pathology, such as ribs with periostitis [30] and calcified pleura [31]. Specific MTBC mycolic 
acids, found in the bacterial cell wall, can provide independent confirmation of tuberculosis 
[31,32], which is of particular significance as the method is based on high performance liquid 
chromatography and there is no amplification of the target molecules. Recently another 
category of cell wall lipid biomarkers, the phthiocerol dimycocerosate waxes, have enabled 
the detection of tuberculosis in archaeological material by the use of negative ion chemical 
ionisation gas chromatography mass spectrometry of their diagnostic mycocerosic acid 
components. Redman et al [33] investigated a group of 49 individuals from the 1837–1936 
Coimbra Identified Skeletal Collection (Portugal), half of whom had records giving 
tuberculosis as a cause of death. There was a 72% correlation between detection of 
mycocerosate acid biomarkers with individuals who were listed as likely to have died from 
tuberculosis.  
 
Re-evaluation of tuberculosis palaeopathology as elucidated by biomolecular 
techniques 
It had been observed by Baron et al [34] that bone samples from sites with obvious 
pathology, and from the same bone but of apparently normal appearance, were positive for 
MTBC aDNA. Their specimens were from a historical collection of individuals given a 
diagnosis of tuberculosis at autopsy and they concluded that the tubercle bacilli had been 
carried into the bone with the bloodstream. They speculated further that this raised the 
possibility that other infectious agents retrievable in blood should be detectable by PCR in 
the absence of lesions – a supposition now known to be correct [28]. 
 
A small study of skeletal remains from 15th–17th century Lithuania may have been the first 
to deliberately include bones from individuals with no bone pathology. Faerman et al [35] 
examined pathological lesions versus healthy tissue from the same skeleton, using four 
individuals. Three additional skeletal remains, chosen at random from the same site, were 
also examined, plus soil samples to test the specificity of the PCR primers. Compact bone 
and teeth were examined. All seven individuals contained MTBC aDNA. One soil sample 
was also positive but further analysis showed that only a sub-specimen that contained small 
pieces of skin and cartilage was positive. The authors concluded that they had obtained 
direct evidence for haematogenous spread of tubercle bacilli. They observed that many 
clinical forms of tuberculosis leave no specific traces on the skeleton, and suggested the 
disease may be detectable even in individuals represented by only a single bone or tooth.  
 
Zink et al [30] examined the relationship between morphological bony changes and 
tuberculosis in ancient Egypt. They examined 41 bones: 37 from the necropolis of Thebes-
West (2120–500 BC) and four bones from the necropolis of Abydos (3000 BC). Only three 
subjects had pathological changes typical of tuberculosis, whilst 17 showed non-specific 
pathology but were likely to be due to tuberculosis. The remaining 20 specimens were 
viewed as controls and had no visible pathology. Of 30 specimens that demonstrated human 
DNA, nine samples were positive for MTBC DNA: two of the three with typical pathology, 
5/13 non-specific but probable cases of tuberculosis (including two from 3000 BC), and 2/14 
with no pathological changes.  
 
Mays et al [36] noted that tuberculous lesions in the ribs arise by extension from spinal 
lesions, from haematogenous spread from some remote soft-tissue focus, or by direct 
spread from disease in the lungs, pleura, or chest-wall lymphatic system. In the clinical 
literature lytic lesions, caused by dissemination of disease from remote soft-tissue foci via 
the bloodstream, are believed to be the most frequent form of rib involvement in tuberculosis 
and in such cases bony changes would not be anticipated. Mays et al examined 14 ribs from 
a deserted mediaeval village in northeast England (10th–16th century AD), seven with 
pathological surface pathology and seven forming an age and sex-matched control group, 
but with no visual or radiological sign of pathology. MTBC aDNA was detected in one rib with 
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pathology and two control ribs, indicating that the absence of visible pathology does not 
preclude detection of tuberculous biomarkers. The failure to detect MTBC aDNA in bones 
with pathology is most likely due to poor DNA preservation and/or localised distribution 
within the bone.  
 
A further example of the detection of tuberculosis in the absence of visible markers is given 
by a study of skin tissues from 12 Pre-Columbian (140–1240 AD) Andean mummies, where 
Konomi et al [37] demonstrated MTBC DNA in two individuals. In addition, the study by 
Redman et al [33] reported that there were no visible signs of tuberculosis in 11 of the 49 
skeletons that were positive for mycocerosates. Therefore both MTBC aDNA and cell wall 
lipid biomarkers have demonstrated the molecular traces of tuberculosis in the absence of 
specific palaeopathology. 
 
When MTBC aDNA was detected in bones from individuals with no obvious palaeopathology 
at all [30,35,36], this initially attracted criticism and the assumption of laboratory 
contamination, until anthropologists realised the low proportion of skeletal tuberculosis in 
clinical infections from the recent pre-antibiotic era. It is estimated that bone tuberculosis 
occurs in only 3–5% of infections [38], and that the spine is involved in around 40% of these. 
Therefore, the earlier views of the incidence of tuberculosis based solely on bone 
morphology were necessarily severe under-estimates. The detailed studies on relationship 
of rib lesions with tuberculosis [5–7] had indicated that this might be the case, but until the 
use of specific aDNA and lipid biomarkers, this could not be proved (Panel 1).  
 
Identification of strains and lineages 
The parallel development of molecular diagnostics, and increased understanding of the 
MTBC genome, encouraged efforts to identify individual members of the MTBC in ancient 
material and to distinguish between strains and lineages. Methods are based mainly on copy 
number of repetitive sequences, deletion analysis and single nucleotide polymorphisms 
(SNPs). Sreevatsan et al [39] described three SNP types based on katG463 CTG to CGG and 
subsequent gyrA95 ACC to AGC mutations, thereby proposing an evolutionary pathway of 
the tubercle bacilli.  
 
Spoligotyping is based on the direct repeat (DR) region of the MTBC [40]. PCR primers in 
the DR region amplify up to 43 unique spacer regions that lie between each DR locus. The 
spacers are visualised by dot-blot hybridisation on a membrane giving a fingerprint and 
patterns are stored on an international database. Thus, Taylor et al [41] were able to 
demonstrate, using spoligotyping and SNPs, that bones from Mediaeval London (1350–1538 
AD) were infected with M. tuberculosis rather than Mycobacterium bovis. Both human and 
cattle bones with periostitis from an earlier mediaeval site in northern England were 
examined for M. tuberculosis and M. bovis [42], but only M. tuberculosis was detected and 
only in human remains. Indeed, to date there is only one site where human archaeological 
cases of M. bovis have been identified, and this of Iron Age pastoralists (360 BC–230 AD) 
from southern Siberia [43,44]. 
 
Animal bones have proved a difficult subject for the study of past tuberculosis. There is one 
report of an Iroquoian dog from the 16th century, with the tuberculosis-associated but non-
specific palaeopathological condition HOA [45], in which MTBC aDNA was found. A 
histological study of the HOA pathological lesions in these remains [46] indicated that the 
dog had experienced a long and most likely arduous period of illness. The animal was buried 
with purpose and lived within a longhouse environment [45], thus providing the perfect 
opportunity for the transmission of an interspecies (and intraspecies) tuberculosis infection. 
 
However, the rarity of animals in the pathological record is, no doubt, because most 
collections of animal bones are from domesticated animals used for food. These rarely live a 
sufficient time to develop recognisable lesions or to die a natural death. Once killed, 
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carcases will be butchered, cooked and eaten. Bones will be used if possible, and if not, 
discarded. An exception to this scenario was discovered in the Natural Trap Cave in 
Wyoming, USA. This cave is 30 m deep and presents an unavoidable hazard on a game 
trail, thereby providing an unbiased sample over >100,000 years of the many passing 
species. Due to the depth of the cave, falls are invariably fatal, and the temperature remains 
constant at 4–5 oC, conditions known to be conducive for aDNA persistence. 
Palaeopathological changes were occasionally noted in bovids and a metatarsal from an 
extinct long-horned bison (17,870 ± 230 BP) was found to contain MTBC aDNA [47]. Further 
characterisation was attempted and consensus spoligotyping indicated an ancestral version 
of the MTBC DR region, rather than the typing patterns associated with M. bovis or most 
extant strains of M. tuberculosis. 
 
The first indication of human tuberculosis infections caused by another member of the 
MTBC was in a population study from Thebes West in ancient Egypt [48]. Spoligotyping 
indicated M. tuberculosis was present in most of the infected individuals, but there appeared 
to be one case where M. africanum was implicated. A follow-up study of bone and soft tissue 
samples from 118 individuals compared the incidence of tuberculosis over three time 
periods. This revealed several samples with an M. africanum spoligotype pattern from a 
Middle Kingdom tomb (2050 –1650 BC), whilst samples from later periods were all typical of 
M. tuberculosis [49]. There was no indication of M. bovis. The authors concluded that these 
findings did not support the theory that M. tuberculosis had evolved from M. bovis. 
 
Palaeoepidemiology of tuberculosis 
To estimate disease prevalence over a long time span, the occurrence of tuberculosis in 
vertebral bones only was examined at Thebes-West in Ancient Egypt. Specimens were from 
three time periods: the pre-dynastic to early dynastic period (c. 3500–2650 BC), the Middle 
Kingdom to Second Intermediate Period (c. 2100–1550 BC) and the New Kingdom to the 
Late Period (c. 1450–500 BC) [50]. MTBC aDNA was found in 18 of the 50 individuals with 
detectable human aDNA throughout these time periods, indicating the long-term association 
of host and bacterial pathogen. There were more positives in individuals with typical 
tuberculosis pathology, but 7/50 positive cases had bones of normal appearance.  
 
A population study from a more recent, but exceptionally well-preserved collection of 
naturally mummified or partially mummified remains, was based on a collection of 263 
individuals buried during the 18th century, in a church crypt that was sealed and only re-
discovered in the early 1990's [51,52]. Contemporaneous civic and church records were 
available, so it was possible to determine tuberculosis prevalence according to age, sex, 
occupation and family group. Tuberculosis was assessed initially by visual and radiographic 
evidence of palaeopathology and contemporary records. Independent research groups 
determined the presence of MTBC aDNA and found over 60% of individuals to be infected 
[18]. Molecular typing showed that three members of a family group were infected with 
separate strains of M. tuberculosis. A mother was infected with a different SNP genotype 
[39] from her two daughters [52], thus suggesting that in this high-incidence population, 
infection was acquired from the community, not within the family.  
 
An intriguing aspect of palaeomicrobiology is the ability to detect co-infections by the use of 
specific biomarkers. Donoghue et al [53] detected both MTBC and Mycobacterium leprae 
aDNA in skeletal material from individuals with obvious palaeopathology for lepromatous 
leprosy. This had been prompted by reports in the clinical literature of leprosy patients dying 
of tuberculosis, as M. tuberculosis is the more virulent pathogen in such patients. Other past 
populations with molecular evidence of two or more infectious diseases include the Early 
Christian Nubian population of Kulubnarti, where both tuberculosis and leishmaniasis were 
identified, and 15th–16th century 'wet' Korean mummies in which many intestinal parasites, 
tuberculosis, and hepatitis B virus have been detected [18]. 
 
 6 
 
Setting the molecular clock – direct determination of past MTBC lineages 
Brosch et al [54] demonstrated that the SNP types identified by Sreevatsan et al [39] 
occurred in a lineage of M. tuberculosis strains that had already lost TbD1 (Fig.1), and re-
defined them as markers of three Principal Genetic Groups (PGGs). The results by Fletcher 
et al [51] therefore demonstrated that M. tuberculosis aDNA amplified from naturally 
mummified Hungarians from the 18th and 19th century belonged to katG463/gyrA95 PGG2 
and PGG3, and that the TbD1 deletion occurred in the lineage of M. tuberculosis before the 
18th century. At the time of publication this was of interest, as it suggested the dramatic 
increase of tuberculosis cases later in the 18th century in Europe involved the TbD1-deleted 
M. tuberculosis strains that are now prevalent in the developed world. It also provided a 
further demonstration that tuberculosis was caused by M. tuberculosis and not by M. bovis.  
 
The time-scale for the emergence of distinct human lineages was dramatically extended by 
the findings of Hershkovitz et al [55]. Studies from the Pre-Pottery Neolithic site of Atlit Yam 
in the Eastern Mediterranean, dating from 9,250-8,150 BP demonstrated that a woman and 
infant were infected with M. tuberculosis, based on morphological changes to bones, the 
detection of MTBC-specific cell wall lipid biomarkers, and of aDNA. Bones were well 
preserved as the skeletal remains had been buried in thick clay under the sea, and DNA 
preservation was also good so some molecular characterisation was possible. Several 
different target loci were detected, including that of the TbD1 region. This demonstrated that 
these two individuals were infected with M. tuberculosis from a TbD1–deleted lineage.  
 
Phylogenomics of MTBC strains  
The individual members of the MTBC (excluding the strains with smooth colonies classified 
as Mycobacterium canettii) are 99.95% identical, based on nucleotide sequence. This gave 
rise to the suggestion that there had been an evolutionary bottleneck at the time of 
speciation [39], estimated by ancestral sequence inference to have occurred 15,000–20,000 
years ago. However, there are clear differences in phenotype, host tropism and 
pathogenicity, so comparative genomic studies were undertaken.  Brosch et al [54] analysed 
20 variable regions situated around the genome of a representative and diverse set of 100 
MTBC strains, obtained from different hosts and with a broad range of geographical origins. 
The major finding was that MTBC strains have undergone reductive evolution by the 
unidirectional loss of chromosomal sequences. Once a non-repetitive region has been 
deleted it cannot be replaced and the deletion is a biomarker of a clone derived from a single 
cell and all its descendants [56]. The application of deletion analysis thus demonstrates 
unambiguously that M. bovis has undergone numerous deletions relative to M. tuberculosis 
and therefore M. tuberculosis is a more ancestral lineage. The M. tuberculosis specific 
deletion 1 (TbD1) locus is absent from the majority of strains now prevalent in Europe and 
the Americas, but occurs in strains of different geographic origin and in MTBC lineages 
associated with animal hosts. Therefore, Brosch et al [54] and subsequent authors identified 
the TbD1 deletion as a marker of importance in our understanding of the evolution of the 
MTBC. This is supported by total genome sequencing of M. tuberculosis [57] and M. bovis 
[58], which show that the M. bovis genome is slightly smaller in size (98.5%) and has 
undergone 11 deletions in comparison with M. tuberculosis.  
 
In the search for the source of the MTBC Gutierrrez et al [59] re-examined M. canettii, which 
Brosch et al [54] had concluded was a distinct outlier group with the most ancestral 
characteristics. Indeed, it became clear that different strains of M. canettii displayed more 
variation than is found in all the other species or ecotypes [56] in the MTBC. This led the 
authors to the hypothesis that the MTBC had emerged, via an evolutionary bottleneck, from 
a postulated species with the expected range of internal clonal variation, termed 
“Mycobacterium prototuberculosis”.  Using synonymous sequence diversity to estimate the 
minimal age of the last common ancestor, they concluded that the bacteria responsible for 
tuberculosis have co-evolved with early humans since at least the time of early hominids 
between 2.6 and 2.8 million years ago.  There is continuing debate about this suggested 
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scenario, but meanwhile a possible case of tuberculosis in Homo erectus dated to 490–510 
± 0.05 Ka was described in a partial skeleton discovered in Western Turkey [60]. The 
diagnosis was based on endocranial palaeopathology distinct from SES, termed 
Leptomeningitis tuberculosa, believed to be associated with tuberculous meningitis, but 
critics believe that this diagnosis is premature and based on inadequate evidence [61]. This 
remains an intriguing possibility that awaits the application of next-generation molecular 
methods for clarification. 
 
Relationship of tubercle bacilli to different human societies  
The use of standardised methods of reporting skeletal collections, and the study of past 
populations in the context of their diet, living conditions, work patterns and type of society, 
has facilitated the study of health and disease over time [62]. Evidence of habitations, 
population density, animal domestication, tools and agriculture is supplied by traditional 
archaeological assessments. Carbon and nitrogen stable isotope analysis can give 
information on the type of diet eaten, e.g. terrestrial, marine, freshwater, meat, or dairy. 
Coprolite analysis can also provide data on nutrition and calorie intake, based on 
identification of bones, seeds, pollen etc in preserved faeces. Strontium and oxygen 
isotopes can give an indication of location and mobility during a lifetime. There may also be 
evidence of major climatic events, such as earthquakes and tsunamis changing sea levels, 
or the height of the annual flooding of the Nile [63]. 
 
Tuberculosis is a disease that can exist as a latent infection throughout the lifetime of a host, 
but which may be re-activated or re-acquired when host resistance is impaired. In addition to 
the extremes of life, individuals become susceptible to active disease when suffering from 
poor nutrition, other serious medical conditions, or severe mental or physical stress. Today it 
is estimated by the World Health Organisation that one third of the global population is 
infected with tuberculosis but that only 10% of individuals will develop disease in their 
lifetime (Fig. 2). The implication of the high proportion of latent infections is that there has 
been a prolonged period of co-evolution of host and pathogen. This is also indicated by the 
detection of a TbD1-deleted lineage in the early Neolithic site at Atlit Yam.  
 
Evolutionary biologists have postulated that in the long period of human evolution that pre-
dated the Neolithic, tubercle bacilli occupied an unusual ecological niche in human biology. 
While populations were primarily small, mobile and often family groups, the organisms could 
survive only by surviving throughout the lifetime of their host, with transmission occurring 
from adults with re-activated disease due to an age-related failing immune system, or to 
other severe disease or stress. Infants are more susceptible to acquiring disease, and due to 
their immature immune system, may have a high mortality with primary disseminated 
tuberculosis, thereby providing an opportunity for transmission soon after infection. 
Therefore tubercle bacilli adopt a quasi-commensal relationship with their host in the 
majority of cases [64].  
 
This scenario explains the development of the clonal relationship of the MTBC complex 
members to their host, where particular bacterial lineages are associated with human 
lineages, even in the modern world and in second or third generation inhabitants of 
ethnically diverse cities [65] (Fig. 3). However, when the human population density rises 
significantly there is a greater opportunity for transmission to susceptible hosts, so bacterial 
virulence is likely to increase due to natural selection. This has now been observed by the 
development of evolutionary modern lineages of M. tuberculosis, which induce a lower early 
inflammatory response in the host and demonstrate faster progression to active disease 
[66]. Therefore, reflecting the co-evolution of host and pathogen, it is unsurprising that length 
of urbanisation is a predictor of host genetic resistance to tuberculosis [67].  
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Concluding remarks 
At this time of rapid population growth and the emergence of new virulent M. tuberculosis 
lineages, it is especially important that we understand the history of tuberculosis and 
evolution of the host/pathogen relationship. This chronological review also allows us to 
follow the sequence of observations, emergence of concepts and the changes in our 
perception of this relationship (Panel 2). Palaeomicrobiology offers a unique opportunity to 
detect past lineages that may no longer be extant. It also enables us to calibrate the 
molecular clock when calculating time to Most Recent Common Ancestor by ancestral 
sequence inference. By providing direct evidence of specific biomolecular markers, 
palaeopathologists are able to make better assessments of past prevalence of disease and 
to identify tuberculosis-associated skeletal changes with more confidence. In this regard, it is 
important to extend palaeomicrobiological studies around the world to obtain as 
comprehensive a picture as possible.  The development of next-generation technology and 
additional biomarkers, with greater stability than DNA, should enable us to explore even 
further back into the past. 
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Panel 1. Objectives of studying tuberculosis palaeomicrobiology  
 
 
 
 Confirmation of palaeopathological changes associated with 
tuberculosis 
Gain a better understanding of the majority of past tuberculosis 
infections that leave no visible signs of disease 
To examine ancient tuberculosis in relation to diet, health and 
social structures  
Geographic range in the past in relation to human and 
pathogen lineages 
Comparison of microbial pathogens from the past with those of 
today 
Provision of real-time markers of genetic changes 
Enable monitoring of changes in virulence over a longer time-
scale 
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Panel 2. Insights gained from palaeomicrobiological studies of tuberculosis 
Confirmation of diagnosis from palaeopathology 
Additional palaeopathological indicators of tuberculosis authenticated 
Evidence of haematogenous and direct spread of tubercle bacilli 
within the body 
Understanding that M tuberculosis DNA is in bones with no pathology 
Appreciation that former estimates of tuberculosis infection were far 
too low 
Confirmation of geographical distribution in ancient times e.g. 
tuberculosis existed in Borneo before European contact, in Pre-
Columbian America, and was widespread in ancient Egypt and Rome 
M tuberculosis complex DNA detected in North American bison from 
Pleistocene (17 500 years ago) 
Confirmation of palaeopathological lesions on bovids indicates that M 
tuberculosis in North America was spread from Asia by ungulates that 
crossed the Bering land bridge 
Direct evidence that humans were infected with a TbD1-deleted 
lineage of M. tuberculosis 9000 years ago 
M africanum and M tuberculosis both shown to exist in ancient Egypt 
over 4000 years ago 
M bovis only clearly identified in human remains from Iron Age 
pastoralists in Southern Siberia 
Co-infections identified in some human remains 
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Figure legends 
 
Fig. 1  Working model of the evolutionary scheme of tubercle bacilli [68], which was based 
on earlier versions [54,59].  There is a unidirectional successive loss of DNA and the 
scheme is based on the presence or absence of conserved regions of difference RDs 
(TbD1) and sequence polymorphisms in five selected genes. It is schematic and the 
distances between certain branches do not necessarily correspond to calculated 
phylogenetic differences. 
 
Fig. 2 The global burden of tuberculosis estimated by the World Health Organisation. Each 
section of the pyramid drawn is roughly to scale and the bar to the right represents the 
spectrum of different lesion types seen in latent infections [69]. 
 
Fig. 3 A single clone or small subset of a population of a free-living bacterium (left) invades 
a new pathogenic niche, founding a population of low diversity. The pathogen becomes 
reproductively isolated from the ancestral population (right), and the pathogenic lifestyle 
precludes genetic exchange among members of the clone as it expands into its new niche. 
The accumulation of mutation in different branches generates a fingerprint of polymorphisms 
characteristic of each branch, enabling the phylogeny to be precisely reconstructed from 
whole-genome sequence data [70]. 
